Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis

NCT00236938 Phase 3 COMPLETED Results posted

This is a open-label, prospective study comparing intravenous (IV) iron supplementation to standard care in anemic patents undergoing peritoneal dialysis.

Details

Lead sponsor	American Regent, Inc.
Phase	Phase 3
Status	COMPLETED
Enrolment	121
Start date	2002-07
Completion	2004-10

Conditions

• Anemia

Interventions

• Venofer and stable erythropoietin (EPO) regimen
• stable erythropoietin (EPO) regimen

Primary outcomes

• Mean Change From Baseline to the Highest Hemoglobin up to Day 71 — Change from Baseline up to Day 71